DE69323759T2 - Verwendung von toremifene für die behandlung von sle - Google Patents

Verwendung von toremifene für die behandlung von sle

Info

Publication number
DE69323759T2
DE69323759T2 DE69323759T DE69323759T DE69323759T2 DE 69323759 T2 DE69323759 T2 DE 69323759T2 DE 69323759 T DE69323759 T DE 69323759T DE 69323759 T DE69323759 T DE 69323759T DE 69323759 T2 DE69323759 T2 DE 69323759T2
Authority
DE
Germany
Prior art keywords
treatment
toremifene
sle
glucocorticoid
estrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69323759T
Other languages
English (en)
Other versions
DE69323759D1 (de
Inventor
Junpei Itoh
Osamu Miyazaki
Hisao Ekimoto
Michinori Koyama
Tetsushi Saino
Lauri Kangas
Anni Warri
Christer Granberg Chr Granberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Nippon Kayaku Co Ltd
Original Assignee
Orion Yhtyma Oy
Nippon Kayaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtyma Oy, Nippon Kayaku Co Ltd filed Critical Orion Yhtyma Oy
Publication of DE69323759D1 publication Critical patent/DE69323759D1/de
Application granted granted Critical
Publication of DE69323759T2 publication Critical patent/DE69323759T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
DE69323759T 1992-10-27 1993-10-26 Verwendung von toremifene für die behandlung von sle Expired - Fee Related DE69323759T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31077292 1992-10-27
PCT/JP1993/001543 WO1994009764A1 (en) 1992-10-27 1993-10-26 Use of non steroidal anti estrogens for autoimmune diseases

Publications (2)

Publication Number Publication Date
DE69323759D1 DE69323759D1 (de) 1999-04-08
DE69323759T2 true DE69323759T2 (de) 1999-07-22

Family

ID=18009292

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69323759T Expired - Fee Related DE69323759T2 (de) 1992-10-27 1993-10-26 Verwendung von toremifene für die behandlung von sle

Country Status (12)

Country Link
US (3) US6355688B1 (de)
EP (2) EP0667768B1 (de)
KR (1) KR100303634B1 (de)
CN (1) CN1053337C (de)
AT (1) ATE177008T1 (de)
AU (1) AU5286693A (de)
DE (1) DE69323759T2 (de)
DK (1) DK0667768T3 (de)
ES (1) ES2128441T3 (de)
GR (1) GR3029682T3 (de)
NO (2) NO314533B1 (de)
WO (1) WO1994009764A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0710116B1 (de) * 1993-05-13 2008-09-03 Poniard Pharmaceuticals, Inc. Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
US5521198A (en) * 1993-12-21 1996-05-28 Eli Lilly And Company Methods of inhibiting autoimmune diseases
EP0981337A4 (de) * 1997-02-09 2003-03-12 Pharmos Corp Erhoehte anti-angiogene aktivitaet von permanent geladenen steroidhormonderivaten
WO1998039755A2 (en) 1997-03-06 1998-09-11 Nashua Corporation Display with polarisation-maintaining diffusing sheet
EP1253966B1 (de) * 1999-08-13 2011-04-27 Curadis GmbH Substanzen und mittel zur positiven beeinflussung von kollagen
US20020013327A1 (en) * 2000-04-18 2002-01-31 Lee Andrew G. Compositions and methods for treating female sexual dysfunction
US7069444B2 (en) * 2002-01-25 2006-06-27 Brent A. Lowensohn Portable wireless access to computer-based systems
US9040507B2 (en) * 2008-06-02 2015-05-26 Novelmed Therapeutics, Inc. Method for treating inflammatory conditions
AU2010210344B2 (en) 2009-02-09 2016-02-25 Swimc Llc In-store tintable non-infrared-absorptive paint and stain system
MX2011008406A (es) 2009-02-09 2012-01-12 Valspar Sourcing Inc Sistema de pintura y tiene no absorbente de radiacion infrarroja coloreable en tienda.
BR112012031897A2 (pt) 2010-07-01 2016-11-08 Valspar Sourcing Inc composição de revestimento aquosa, componente de construção revestido, e, método para revestir componentes de construção
CN110144148A (zh) 2010-10-20 2019-08-20 威士伯采购公司 具有改善耐湿性和耐热性的水基涂料体系
RU2572504C1 (ru) * 2013-12-26 2016-01-10 Андрей Константинович Иорданишвили Способ лечения лучевой сиалоаденопатии
US11077597B2 (en) 2016-02-23 2021-08-03 Moistureshield, Inc. Compositions and methods for reducing the surface temperature of composite articles
AU2018205039B2 (en) 2017-01-01 2022-09-22 Moistureshield, Inc. Methods for coating composite articles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU172948B (hu) 1976-02-05 1979-01-28 Gyogyszerkutato Intezet Sposob poluchenija osnovnykh proizvodnykh trifenil-alkenov
EP0002097B1 (de) 1977-08-22 1981-08-05 Imperial Chemical Industries Plc Triphenylalken-Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
DE3046719C2 (de) 1980-12-11 1983-02-17 Klinge Pharma GmbH, 8000 München 1,1,2-Triphenyl-but-1-en-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel
GB2126576B (en) * 1982-06-25 1985-06-19 Farmos Group Limited Alkane and alkene derivatives
FI67538C (fi) 1982-05-27 1985-04-10 Farmos Oy Foerfarande foer framstaellning av (z)-1,2-difenyl-1-(4-(2-(n n-dimetylamino)etoxi)fenyl)-1-buten
US5348729A (en) * 1988-11-30 1994-09-20 The United States Of America As Represented By The Department Of Health And Human Services Evaluative means for detecting inflammatory reactivity
US4990538A (en) 1989-08-23 1991-02-05 Harris Adrian L Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs
JPH04312526A (ja) * 1991-04-09 1992-11-04 Fujisawa Pharmaceut Co Ltd 骨疾患治療剤

Also Published As

Publication number Publication date
NO20025179D0 (no) 2002-10-28
US6387958B1 (en) 2002-05-14
AU5286693A (en) 1994-05-24
GR3029682T3 (en) 1999-06-30
US20020107231A1 (en) 2002-08-08
DE69323759D1 (de) 1999-04-08
EP0667768B1 (de) 1999-03-03
CN1053337C (zh) 2000-06-14
CN1100930A (zh) 1995-04-05
EP0667768A1 (de) 1995-08-23
US6355688B1 (en) 2002-03-12
NO317544B1 (no) 2004-11-08
WO1994009764A1 (en) 1994-05-11
DK0667768T3 (da) 1999-09-27
NO20025179L (no) 1995-04-26
ES2128441T3 (es) 1999-05-16
ATE177008T1 (de) 1999-03-15
NO314533B1 (no) 2003-04-07
NO951596D0 (no) 1995-04-26
US6458848B1 (en) 2002-10-01
NO951596L (no) 1995-04-26
EP0776661A1 (de) 1997-06-04
KR940008677A (ko) 1994-05-16
KR100303634B1 (ko) 2001-11-22

Similar Documents

Publication Publication Date Title
DE69323759D1 (de) Verwendung von toremifene für die behandlung von sle
DE69414176D1 (de) Verfahren zur Herstellung von N-Acyl-N,N',N'-Ethylendiamintriessigsäurederivaten
ATE126433T1 (de) Verwendung von gamma-hydroxy-buttersäuresalzen zur herstellung von pharmazeutischen zusammensetzungen zur verwendung bei der behandlung von alkoholismus und die hergestellten zusammensetzungen.
IT1236831B (it) Apparecchio per il trattamento dell'intestino in particolare per enteroclisma
DE69314950T2 (de) Okulaerdarreichungsform und verfahren zu ihrer herstellung
DE69331605D1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
AU5778090A (en) 11B-aryl-4-estrenes, process for their preparation as well as their use as pharmaceutical agents
DE3583220D1 (de) Verwendung von dipeptidderivaten fuer die herstellung von arzneimitteln zur behandlung von an amyotropher lateralsklerose erkrankten.
PT862575E (pt) Novos derivados de geranilgeranilo processo para a sua preparacao e composicoes farmaceuticas relacionadas
HU906967D0 (en) Fungicide preparatives containing new amino acid amine derivatives as active substance and process for producing the active substances
DE69214608D1 (de) Kristallmodifikation von 2-(3-Methylanilino)-3-Methyl-6-Diethylaminofluoran, Verfahren zur dessen Herstellung und Aufzeichnungsmaterial, welches diese Kristallmodifikation enthält
AU4012893A (en) Method for inducing the acrosome reaction in human and animal spermatozoa
DE68920896T2 (de) N2-(1-Carboxy-3-phenylpropyl)-L-lysinderivate und Verfahren für die Herstellung von Lysinopril mit Hilfe dieser Verbindung.
EE9600023A (et) Fenüültsükloheksüülkarboksüülhappeamiidid, nende valmistamismeetod, kasutamine ravimite valmistamiseks, nimetatud ühendeid sisaldavad ravimid ja nende valmistamismeetod
DE69408484D1 (de) 6,7-Dialkoxy-3,4-dihydroisochinolin-8-ol, Verfahren für seine Herstellung und die Verbindung verwendendes Verfahren für die Herstellung von 6,7-Dialkoxy-1,2,3,4-tetrahydroisochinolin-8-ol
JPS5583758A (en) Novel 3*44diazaabicyclo*4*1*0*heptenee*2**onee *5**its manufacture and medicine containing it
DE551180T1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
DE3861271D1 (de) Basisch substituierte benzofurancarbonsaeureamide, verfahren zu ihrer herstellung und sie enthaltende therapeutische mittel.
IT1170238B (it) Impiego di ibuprofene e flurbiprofene nella cura dell'erpete
AU634584B2 (en) Aroyl-ureas
IT1252659B (it) Procedimento per la depurazione dell'1,1,1-trifluoro-2-fluoroetano e dell'1,1,1-trifluoro-2,2-dicloroetano
FI980947A0 (fi) Zeaksantiinin puhdas 3R-3'R-stereoisomeeri silmän keltatäplämuutoksen hoitamiseksi
DE69632117D1 (de) Verwendung von 8,9-Dehydroestron zur Herstellung eines Arzneimittels zur Behandlung von durch freie Radikale verursachte Krankheiten
DE59305709D1 (de) Verfahren zur Herstellung von 1,4-Diaminoanthrachinon-2,3-disulfonsäure und 1,4-Diaminoanthrachinon-2,3-dinitril
ITMI941939A0 (it) Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee